Anthera Pharmaceuticals Inc (ANTH PINK) stock market data APIs
$0.0001
0(0%)
as of December 8, 2025
Try our APIs with
free plan!
Anthera Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.
Prev. Close
0.0001
Open
0.0001
High
0.0001
Low
0.0001
52 wk Range
0.0001-0.001
Market Cap
2 617
Shares Outstanding
26 179 K
EPS
0
Beta
-88.896
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Anthera Pharmaceuticals Inc data using free add-ons & libraries
Get Anthera Pharmaceuticals Inc Fundamental Data
Anthera Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -36 402 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-18
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Anthera Pharmaceuticals Inc News
New
GitLab stock sinks, Anthropic reportedly planning an IPO
Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including GitLab (GTLB) stock continuing to sink, CrowdStrike (CRWD) shares slipping despite topping third qua...
Microsoft stock falls on reported AI sales quota cut
Microsoft (MSFT) stock is under pressure following a report from The Information that the company has lowered some artificial intelligence (AI) sales quotas. Yahoo Finance Tech Editor Dan Howley exam...
Alphabet's AI, ADP job data, Macy's & Dollar Tree: 3 Things
Alphabet (GOOG, GOOGL) is taking the AI ecosystem by force with the latest iteration of its Nano Banana generator and Gemini chatbot, while Anthropic (ANTH.PVT) is reportedly eyeing an IPO. US stock ...
Amazon releases new AI chip amid industry push to challenge Nvidia's dominance
Amazon (AMZN) released a new AI chip on Tuesday, marking the latest move by a tech giant to challenge leading chipmaker Nvidia (NVDA) by introducing custom chips that can handle some AI tasks at cheap...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
